View : 571 Download: 0
CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB
- Title
- CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB
- Authors
- Do, Y. R.; Kwak, J. -Y.; Kim, H.; Kim, J. -A.; Kim, H. J.; Park, J. S.; Chung, J. S.; Shin, H. -J.; Kim, S. -H.; Kim, D. -Y.; Bunworasate, U.; Choi, C. W.; Comia, N. S.; Zang, D. Y.; Oh, S. J.; Jootar, S.; Reksodiputro, A. H.; Lee, W. S.; Mun, Y. -C.; Kong, J. H.; Caguioa, P. B.; Park, J.; Jung, C. W.; Kim, D. -W.
- Ewha Authors
- 문영철
- Issue Date
- 2017
- Journal Title
- HAEMATOLOGICA
- ISSN
- 0390-6078
- Citation
- HAEMATOLOGICA vol. 102, pp. 441 - 441
- Publisher
- FERRATA STORTI FOUNDATION
- Document Type
- Meeting Abstract
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
03760 서울특별시 서대문구 이화여대길 52 이화여자대학교 도서관
COPYRIGHT 2016 BY EWHA WOMANS UNIVERSITY. ALL RIGHTS RESERVED
이화여자대학교 리포지터리는 국립중앙도서관 OAK 보급사업으로 구축되었습니다. Feedback